TY - JOUR AU - Paul, S. M. AU - Mytelka, D. S. AU - Dunwiddie, C. T. AU - Persinger, C. C. AU - Munos, B. H. AU - Lindborg, S. R. PY - 2010 DA - 2010// TI - How to improve R&D productivity: the pharmaceutical industry’s grand challenge JO - Nat Rev Drug Discov VL - 9 ID - Paul2010 ER - TY - CHAP AU - Wehling, M. ED - Wehling, M. PY - 2015 DA - 2015// TI - Introduction and definitions BT - Principles of translational science in medicine from bench to bedside PB - Elsevier CY - Heidelberg ID - Wehling2015 ER - TY - JOUR AU - Cook, D. AU - Brown, D. AU - Alexander, R. AU - March, R. AU - Morgan, P. AU - Satterthwaite, G. PY - 2014 DA - 2014// TI - Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework JO - Nat Rev Drug Discov VL - 13 UR - https://doi.org/10.1038/nrd4309 DO - 10.1038/nrd4309 ID - Cook2014 ER - TY - JOUR AU - Wehling, M. PY - 2009 DA - 2009// TI - Assessing the translatability of drug projects: what needs to be scored to predict success? JO - Nat Rev Drug Discov VL - 8 UR - https://doi.org/10.1038/nrd2898 DO - 10.1038/nrd2898 ID - Wehling2009 ER - TY - JOUR AU - Wehling, M. PY - 2006 DA - 2006// TI - Translational medicine: can it really facilitate the transition of research “from bench to bedside”? JO - Eur J Clin Pharmacol VL - 62 UR - https://doi.org/10.1007/s00228-005-0060-4 DO - 10.1007/s00228-005-0060-4 ID - Wehling2006 ER - TY - JOUR AU - Morgan, P. AU - Graaf, P. H. AU - Arrowsmith, J. AU - Feltner, D. E. AU - Drummond, K. S. AU - Wegner, C. D. PY - 2012 DA - 2012// TI - Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival JO - Drug Discov Today VL - 17 UR - https://doi.org/10.1016/j.drudis.2011.12.020 DO - 10.1016/j.drudis.2011.12.020 ID - Morgan2012 ER - TY - JOUR AU - Campbell, S. J. AU - Gaulton, A. AU - Marshall, J. AU - Bichko, D. AU - Martin, S. AU - Brouwer, C. PY - 2010 DA - 2010// TI - Visualizing the drug target landscape JO - Drug Discov Today VL - 15 UR - https://doi.org/10.1016/j.drudis.2009.09.011 DO - 10.1016/j.drudis.2009.09.011 ID - Campbell2010 ER - TY - JOUR AU - Wendler, A. AU - Wehling, M. PY - 2012 DA - 2012// TI - Translatability scoring in drug development: eight case studies JO - J Transl Med VL - 10 UR - https://doi.org/10.1186/1479-5876-10-39 DO - 10.1186/1479-5876-10-39 ID - Wendler2012 ER - TY - JOUR AU - Lieu, C. H. AU - Tan, A. C. AU - Leong, S. AU - Diamond, J. R. AU - Eckhardt, S. G. PY - 2013 DA - 2013// TI - From bench to bedside: lessons learned in translating preclinical studies in cancer drug development JO - J Natl Cancer Inst VL - 105 UR - https://doi.org/10.1093/jnci/djt209 DO - 10.1093/jnci/djt209 ID - Lieu2013 ER - TY - JOUR AU - Kalia, M. AU - Costa, E. S. J. PY - 2015 DA - 2015// TI - Biomarkers of psychiatric diseases: current status and future prospects JO - Metabolism VL - 64 UR - https://doi.org/10.1016/j.metabol.2014.10.026 DO - 10.1016/j.metabol.2014.10.026 ID - Kalia2015 ER - TY - STD TI - Thomas DW, Burns J, Audette J, Carroll A, Dow-Hygelund C, Hay M. Clinical development success rates 2006–2015. In: BIO Industry Analysis, Amplion, Inc, Biomedtracker, Biotechnology Innovation Organization (BIO) 2016. p. 1–16. https://www.bio.org/sites/default/files/Clinical. Development success rates 2006–2015—BIO, Biomedtracker, Amplion 2016.pdf. Assessed 25 June 2017. UR - https://www.bio.org/sites/default/files/Clinical ID - ref11 ER - TY - JOUR AU - Nagle, P. C. AU - Nicita, C. A. AU - Gerdes, L. A. AU - Schmeichel, C. J. PY - 2008 DA - 2008// TI - Characteristics of and trends in the late-stage biopharmaceutical pipeline JO - Am J Manag Care VL - 14 ID - Nagle2008 ER - TY - JOUR AU - Kannt, A. AU - Wieland, T. PY - 2016 DA - 2016// TI - Managing risks in drug discovery: reproducibility of published findings JO - Naunyn Schmiedebergs Arch Pharmacol VL - 389 UR - https://doi.org/10.1007/s00210-016-1216-8 DO - 10.1007/s00210-016-1216-8 ID - Kannt2016 ER - TY - STD TI - FDA, 2016 Novel Drugs Summary. https://www.fda.gov/drugs/developmentapprovalprocess/druginnovation/ucm534863.htm. Assessed 3 May 2017. UR - https://www.fda.gov/drugs/developmentapprovalprocess/druginnovation/ucm534863.htm ID - ref14 ER - TY - JOUR AU - Throm, S. PY - 2017 DA - 2017// TI - Aktivitäten von CHMP und CMDh JO - Pharm Ind VL - 79 ID - Throm2017 ER - TY - STD TI - New drug approvals fall to six-year low in 2016. http://www.reuters.com/article/us-pharmaceuticals-approvals-idUSKBN14M08R. Assessed 6 May 2017. UR - http://www.reuters.com/article/us-pharmaceuticals-approvals-idUSKBN14M08R ID - ref16 ER - TY - JOUR AU - Agarwal, A. AU - Ressler, D. AU - Snyder, G. PY - 2015 DA - 2015// TI - The current and future state of companion diagnostics JO - Pharmgenomics Pers Med VL - 8 ID - Agarwal2015 ER - TY - STD TI - List of Cleared or Approved Companion Diagnostic Devices (In Vitro and Imaging Tools). https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm301431.htm. Assessed 10 Jan 2017. UR - https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm301431.htm ID - ref18 ER - TY - STD TI - Human Immunodeficiency Virus-1 Infection. Developing Antiretroviral Drugs for Treatment Guidance for Industry. https://www.fda.gov/downloads/drugs//ucm355128pdf 2015. Assessed 20 Feb 2017. UR - https://www.fda.gov/downloads/drugs//ucm355128pdf ID - ref19 ER - TY - STD TI - Chronic Hepatitis C Virus Infection: Developing direct-acting antiviral drugs for treatment guidance for industry DRAFT GUIDANCE https://www.fda.gov/downloads/drugs/…/ucm225333.pdf. Assessed 20 Feb 2017. UR - https://www.fda.gov/downloads/drugs/%e2%80%a6/ucm225333.pdf ID - ref20 ER - TY - JOUR AU - Schilsky, R. L. PY - 2010 DA - 2010// TI - Personalized medicine in oncology: the future is now JO - Nat Rev Drug Discov VL - 9 UR - https://doi.org/10.1038/nrd3181 DO - 10.1038/nrd3181 ID - Schilsky2010 ER - TY - JOUR AU - Camus, S. AU - Ko, W. K. AU - Pioli, E. AU - Bezard, E. PY - 2015 DA - 2015// TI - Why bother using non-human primate models of cognitive disorders in translational research? JO - Neurobiol Learn Mem VL - 124 UR - https://doi.org/10.1016/j.nlm.2015.06.012 DO - 10.1016/j.nlm.2015.06.012 ID - Camus2015 ER - TY - JOUR AU - McGonigle, P. PY - 2014 DA - 2014// TI - Animal models of CNS disorders JO - Biochem Pharmacol VL - 87 UR - https://doi.org/10.1016/j.bcp.2013.06.016 DO - 10.1016/j.bcp.2013.06.016 ID - McGonigle2014 ER - TY - JOUR AU - Hatziioannou, T. AU - Evans, D. T. PY - 2012 DA - 2012// TI - Animal models for HIV/AIDS research JO - Nat Rev Microbiol VL - 10 UR - https://doi.org/10.1038/nrmicro2911 DO - 10.1038/nrmicro2911 ID - Hatziioannou2012 ER - TY - JOUR AU - Zhuang, D. M. AU - Li, J. Y. PY - 2010 DA - 2010// TI - A few specialized issues that should be focused on anti-HIV drug evaluation in vitro JO - Virol Sin VL - 25 UR - https://doi.org/10.1007/s12250-010-3139-8 DO - 10.1007/s12250-010-3139-8 ID - Zhuang2010 ER - TY - BOOK PY - 1999 DA - 1999// TI - Handbook of animal models of infection PB - Elsevier Ltd. CY - Amsterdam ID - ref26 ER - TY - JOUR AU - Jenkins, S. G. AU - Schuetz, A. N. PY - 2012 DA - 2012// TI - Current concepts in laboratory testing to guide antimicrobial therapy JO - Mayo Clin Proc VL - 87 UR - https://doi.org/10.1016/j.mayocp.2012.01.007 DO - 10.1016/j.mayocp.2012.01.007 ID - Jenkins2012 ER - TY - JOUR AU - Scudellari, M. PY - 2016 DA - 2016// TI - How iPS cells changed the world JO - Nature VL - 534 UR - https://doi.org/10.1038/534310a DO - 10.1038/534310a ID - Scudellari2016 ER - TY - JOUR AU - Dracopoli, N. C. AU - Boguski, M. S. PY - 2017 DA - 2017// TI - The evolution of oncology companion diagnostics from signal transduction to immuno-oncology JO - Trends Pharmacol Sci VL - 38 UR - https://doi.org/10.1016/j.tips.2016.09.007 DO - 10.1016/j.tips.2016.09.007 ID - Dracopoli2017 ER - TY - JOUR AU - Ruggeri, B. A. AU - Camp, F. AU - Miknyoczki, S. PY - 2014 DA - 2014// TI - Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery JO - Biochem Pharmacol VL - 87 UR - https://doi.org/10.1016/j.bcp.2013.06.020 DO - 10.1016/j.bcp.2013.06.020 ID - Ruggeri2014 ER -